VTR logo

Ventas, Inc. (VTR)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Ventas, Inc. (VTR) with AI Score 53/100 (Hold). Ventas, Inc. is a leading Real Estate Investment Trust (REIT) focused on healthcare properties. The company owns and manages a diversified portfolio, partnering with healthcare providers and organizations. Market cap: $0, Sector: Real estate.

Last analyzed: Feb 4, 2026
Ventas, Inc. is a leading Real Estate Investment Trust (REIT) focused on healthcare properties. The company owns and manages a diversified portfolio, partnering with healthcare providers and organizations.
53/100 AI Score

Ventas, Inc. (VTR) Real Estate Portfolio & Strategy

CEODebra A. Cafaro
Employees498
HeadquartersChicago, IL, US
IPO Year1997

Ventas, Inc. offers investors a notable opportunity to capitalize on the growing demand for healthcare real estate, driven by an aging population and a diversified portfolio of high-quality properties, generating consistent cash flows and superior returns within the S&P 500.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 4, 2026

Investment Thesis

Ventas presents a notable research candidate due to its strategic positioning in the growing healthcare real estate market. The company's diversified portfolio of approximately 1,200 properties, coupled with its partnerships with leading healthcare providers, provides a stable foundation for consistent cash flow generation. With a market capitalization of $36.58 billion and a dividend yield of 2.47%, Ventas offers a blend of income and growth potential. The aging population demographic trend serves as a significant tailwind, driving increased demand for senior housing and healthcare facilities. Ventas's commitment to maintaining a strong balance sheet and generating superior returns further strengthens its investment appeal. The company's focus on high-quality properties and strategic partnerships positions it for continued success in the evolving healthcare landscape. The current P/E ratio of 149.22 suggests potential for valuation improvement as earnings grow.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $36.58 billion, reflecting its significant presence in the healthcare REIT sector.
  • Dividend yield of 2.47%, providing a steady income stream for investors.
  • Gross margin of 42.0%, indicating efficient property management and revenue generation.
  • Operates approximately 1,200 properties as of September 30, 2020, showcasing a diversified portfolio.
  • Beta of 0.77, suggesting lower volatility compared to the overall market.

Competitors & Peers

Strengths

  • Diversified portfolio of healthcare properties.
  • Strong relationships with leading healthcare providers.
  • Experienced management team.
  • Stable cash flow generation.

Weaknesses

  • Exposure to regulatory changes in the healthcare industry.
  • Dependence on tenant performance.
  • Potential for property vacancies.
  • High P/E ratio of 149.22.

Catalysts

  • Ongoing: Demographic trends driving increased demand for senior housing and healthcare facilities.
  • Ongoing: Strategic acquisitions expanding the company's portfolio and geographic reach.
  • Upcoming: Potential for increased rental rates due to strong demand.
  • Ongoing: Continued partnerships with leading healthcare providers.

Risks

  • Potential: Changes in government regulations impacting healthcare reimbursement.
  • Potential: Rising interest rates increasing borrowing costs.
  • Potential: Economic downturn affecting tenant occupancy rates.
  • Ongoing: Competition from other REITs in the healthcare sector.
  • Potential: Unforeseen events impacting property values.

Growth Opportunities

  • Expansion of Life Science Portfolio: Ventas can capitalize on the growing demand for research and development facilities by expanding its life science portfolio. This includes acquiring or developing properties in key innovation hubs and partnering with leading research institutions. The global life science market is projected to reach $2 trillion by 2028, presenting a significant growth opportunity for Ventas. Timeline: Ongoing.
  • Strategic Acquisitions: Ventas can pursue strategic acquisitions of high-quality healthcare properties to expand its geographic footprint and diversify its portfolio. This includes targeting properties in underserved markets or those with strong growth potential. The fragmented nature of the healthcare real estate market provides ample opportunities for accretive acquisitions. Timeline: Ongoing.
  • Development of New Senior Housing Communities: Ventas can develop new senior housing communities to meet the increasing demand from the aging population. This includes building state-of-the-art facilities with a focus on providing high-quality care and amenities. The senior housing market is expected to grow significantly in the coming years, driven by demographic trends. Timeline: Ongoing.
  • Enhancement of Existing Properties: Ventas can enhance its existing properties through renovations, upgrades, and the addition of new services and amenities. This can improve the attractiveness of its properties to tenants and increase rental income. Investing in property improvements can also help Ventas maintain a competitive edge in the market. Timeline: Ongoing.
  • Partnerships with Healthcare Providers: Ventas can strengthen its partnerships with leading healthcare providers to secure long-term leases and ensure high occupancy rates. This includes collaborating on the development of new facilities and providing customized real estate solutions. Strong relationships with healthcare providers are essential for success in the healthcare REIT sector. Timeline: Ongoing.

Opportunities

  • Expansion of life science portfolio.
  • Strategic acquisitions of healthcare properties.
  • Development of new senior housing communities.
  • Growth in the aging population.

Threats

  • Rising interest rates.
  • Economic downturn.
  • Increased competition.
  • Changes in healthcare reimbursement policies.

Competitive Advantages

  • Diversified portfolio of high-quality healthcare properties.
  • Strong relationships with leading healthcare providers.
  • Experienced management team with a proven track record.
  • Access to capital and a strong balance sheet.

About VTR

Ventas, Inc., an S&P 500 company, stands at the intersection of the healthcare and real estate sectors. Founded over two decades ago, Ventas has evolved into one of the world's preeminent Real Estate Investment Trusts (REITs). The company leverages its capital to unlock the value of real estate, forging partnerships with leading care providers, developers, research and medical institutions, innovators, and healthcare organizations. Ventas's success is intrinsically linked to the demographic tailwind of an aging population, which fuels the demand for healthcare services and facilities. Ventas owns or manages approximately 1,200 properties as of September 30, 2020, through unconsolidated joint ventures. Ventas's strategy centers on a high-quality, diversified portfolio of properties and capital sources, enabling it to navigate market cycles effectively. The company's collaborative and experienced team is focused on generating consistent, growing cash flows and delivering superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. Ventas operates primarily in the United States, with a focus on senior housing, medical office buildings, and life science properties.

What They Do

  • Owns and manages a diversified portfolio of healthcare properties.
  • Partners with leading care providers, developers, and research institutions.
  • Provides real estate solutions to healthcare organizations.
  • Develops and acquires healthcare facilities.
  • Focuses on senior housing, medical office buildings, and life science properties.
  • Generates revenue through rental income and property management fees.
  • Operates as a Real Estate Investment Trust (REIT).

Business Model

  • Acquires, develops, and manages healthcare properties.
  • Generates revenue primarily through rental income from tenants.
  • Distributes a significant portion of its earnings to shareholders as dividends.
  • Utilizes a diversified portfolio to mitigate risk and ensure stable cash flow.

Industry Context

Ventas operates within the REIT - Healthcare Facilities industry, which is experiencing growth driven by the aging population and increasing demand for healthcare services. The industry is characterized by long-term leases and stable cash flows. Ventas competes with other REITs such as AvalonBay Communities (AVB), Crown Castle International (CCI), CoStar Group (CSGP), Physicians Realty Trust (DOC), and Equity Residential (EQR). The competitive landscape is influenced by factors such as property location, quality of facilities, and relationships with healthcare providers. Ventas's diversified portfolio and strategic partnerships position it favorably within this competitive environment. The REIT sector benefits from favorable tax treatment and the ability to distribute a significant portion of earnings to shareholders.

Key Customers

  • Senior housing operators.
  • Medical office tenants.
  • Life science companies.
  • Hospitals and healthcare systems.
AI Confidence: 73% Updated: Feb 4, 2026

Financials

Chart & Info

Ventas, Inc. (VTR) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VTR.

Price Targets

Wall Street price target analysis for VTR.

MoonshotScore

53/100

What does this score mean?

The MoonshotScore rates VTR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About VTR

What does Ventas, Inc. do?

Ventas, Inc. is a leading Real Estate Investment Trust (REIT) that focuses on owning, developing, and managing healthcare properties. The company's portfolio includes senior housing communities, medical office buildings, and life science properties. Ventas partners with leading healthcare providers, developers, and research institutions to provide real estate solutions that meet the evolving needs of the healthcare industry. The company generates revenue primarily through rental income from its properties and distributes a significant portion of its earnings to shareholders as dividends, in accordance with REIT regulations. Ventas aims to capitalize on the growing demand for healthcare real estate driven by the aging population and advancements in medical technology.

Is VTR stock worth researching?

VTR stock presents a mixed investment profile. On the positive side, the company benefits from strong demographic tailwinds and a diversified portfolio of healthcare properties, leading to stable cash flows and a 2.47% dividend yield. However, the high P/E ratio of 149.22 suggests that the stock may be overvalued. Investors may want to evaluate the company's growth opportunities, such as expanding its life science portfolio and pursuing strategic acquisitions, against potential risks like rising interest rates and regulatory changes in the healthcare industry. A thorough analysis of Ventas's financial performance and industry outlook is crucial before making an investment decision. The beta of 0.77 indicates lower volatility than the market.

What are the main risks for VTR?

VTR faces several risks inherent to the healthcare REIT sector. Changes in government regulations regarding healthcare reimbursement could significantly impact the profitability of its tenants, leading to lower occupancy rates and rental income. Rising interest rates could increase borrowing costs, affecting the company's ability to finance new acquisitions and developments. An economic downturn could reduce demand for senior housing and medical services, negatively impacting tenant performance. Increased competition from other REITs could put pressure on rental rates and property values. Unforeseen events, such as natural disasters or pandemics, could disrupt operations and damage properties. These risks should be carefully considered when evaluating VTR as an investment.

What are the key factors to evaluate for VTR?

Ventas, Inc. (VTR) currently holds an AI score of 53/100, indicating moderate score. Key strength: Diversified portfolio of healthcare properties.. Primary risk to monitor: Potential: Changes in government regulations impacting healthcare reimbursement.. This is not financial advice.

How frequently does VTR data refresh on this page?

VTR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven VTR's recent stock price performance?

Recent price movement in Ventas, Inc. (VTR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified portfolio of healthcare properties.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider VTR overvalued or undervalued right now?

Determining whether Ventas, Inc. (VTR) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying VTR?

Before investing in Ventas, Inc. (VTR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on information available as of 2020-09-30.
  • AI analysis is based on available data and may not capture all nuances of the company's performance or future prospects.
Data Sources

Popular Stocks